Kamil D. Kaplanov

Moscow, MOW, RU 
Moscow, MOW, RU 

Overview

Kamil Kaplanov practices practicing medicine in Moscow, Russian Federation.

Their clinical expertise encompasses Mantle Cell Lymphoma (MCL), Leukemia, Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 2 clinical trials.

Locations

Moscow, MOW, Russian Federation
Other Locations
Volgograd, VGG, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An International, Phase 3, Open-Label, Randomized Study of BGB-3111 Compared With Bendamustine Plus Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)
An International, Phase 3, Open-Label, Randomized Study of BGB-3111 Compared With Bendamustine Plus Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)
Enrollment Status: Active_not_recruiting
Publish Date: March 09, 2026
Intervention Type: Drug
Study Drugs: Zanubrutinib, Bendamustine, Rituximab, Venetoclax
Study Phase: Phase 3
Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)
Observational Prospective Cohort Study - Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Other
View 1 Less Clinical Trial

16 Total Publications

The role of the PPM1D gene in tumor pathogenesis.
The role of the PPM1D gene in tumor pathogenesis.
Journal: Biomeditsinskaia khimiia
Published: March 06, 2025

Frequently Asked Questions about Kamil D. Kaplanov

Is Kamil D. Kaplanov a top-rated expert for Mantle Cell Lymphoma (MCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Kamil D. Kaplanov is classified as an Experienced expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kamil D. Kaplanov participate in research or clinical trials?

Yes. Kamil D. Kaplanov has published 16 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Kamil D. Kaplanov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kaplanov's expertise for a condition
ConditionClose
        View All 20 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile